Certara Services Archives

Case Study

利用价值传播技术和综合工作流程加快药品上市速度

With early approvals for a targeted cancer drug in Brazil and Argentina, this global pharmaceutical…

Certara2023 年 10 月 2 日

Case Study

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

Otsuka identified several weaknesses in their existing workflow for developing value communication tools. In particular,…

Certara2023 年 10 月 2 日

White Paper

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

Since 2019, the Institute for Clinical and Economic Review (ICER) has published an annual Unsupported…

Certara2023 年 7 月 25 日

Case Study

利用药代动力学建模和科学传播专长推进肉样瘤病药物项目

Certara's support, from dose optimization to medical writing, helps pharmaceutical companies advance their research, make…

Certara2023 年 6 月 1 日

Conference

American College of Toxicology 2025 Annual Meeting

– – Booth

Certara2023 年 5 月 24 日

Conference

ISPOR Europe 2025

–

Certara2023 年 5 月 24 日

Conference

ACoP 2025

Certara2023 年 5 月 24 日

Case Study

转化药理学咨询支持治疗肺分枝杆菌复合病的联合疗法

RedHill Biopharma Ltd., a specialty biopharmaceutical company, developed RHB-204, a treatment for MAC, and needed…

Certara2023 年 5 月 9 日

Case Study

使用 MBMA 进行虚拟 "正面交锋试验"

Osteoporosis is common in post-menopausal women. The long-term sequelae of osteoporosis include bone fractures, particularly…

Certara2023 年 4 月 21 日

Case Study

Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial

Our client was developing a new anti-viral drug for a rare, life-threatening viral infection that…

Certara2023 年 4 月 17 日

Certara 服务

利用价值传播技术和综合工作流程加快药品上市速度

Using customer engagement technology to create value communication tools for ABILIFY MAINTENA® (aripiprazole)

ICER’s Unsupported Price Increase Report: Unfit for Policymaking

利用药代动力学建模和科学传播专长推进肉样瘤病药物项目

American College of Toxicology 2025 Annual Meeting

ISPOR Europe 2025

ACoP 2025

转化药理学咨询支持治疗肺分枝杆菌复合病的联合疗法

使用 MBMA 进行虚拟 "正面交锋试验"

Using Real-World Evidence to Derive an External Control Arm for a Rare Disease Drug Trial

订阅时事通讯

快捷链接

解决方案

联系我们